Compare $NVAX vs $VERA | Chartloom

Compare

$NVAX vs $VERA

Novavax Inc · Vera Therapeutics, Inc

NVAX

Novavax Inc

VERA

Vera Therapeutics, Inc

Compare $NVAX vs $VERA

Comparing Novavax Inc and Vera Therapeutics, Inc

NVAXNovavax Inc

VERAVera Therapeutics, Inc

NVAXNovavax Inc

Market cap

$2.10B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

10.28x

Rev growth (TTM)

-61.6%

YTD performance

78.8%

52W performance

43.3%

FCF yield

-2.0%

VERAVera Therapeutics, Inc

Market cap

$2.14B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.87x

Rev growth (TTM)

—

YTD performance

-38.5%

52W performance

-2.0%

FCF yield

-15.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NVAX

VERA

Detailed metrics comparison

NVAX

Novavax Inc

VERA

Vera Therapeutics, Inc

Market Cap

NVAX$2.10B

VERA$2.14B

Enterprise Value

NVAX$2.20B

VERA$2.17B

Price

NVAX$12.75

VERA$29.88

P/E Ratio

NVAXN/A

VERAN/A

P/S Ratio

NVAX5.07x

VERA0.00x

EV/Sales

NVAX5.32x

VERA0.00x

EV/EBITDA

NVAX4.05x

VERA0.00x

P/B Ratio

NVAX45.86x

VERA5.38x

P/FCF Ratio

NVAXN/A

VERAN/A

EV/FCF

NVAX-51.40x

VERA-6.40x

PEG Ratio

NVAXN/A

VERAN/A

Forward P/E (NTM)

NVAXN/A

VERAN/A

Forward P/S (NTM)

NVAX10.28x

VERA19.87x

Revenue (TTM)

NVAX$414M

VERA$0

Revenue Growth (YoY)

NVAX-61.6%

VERAN/A

Forward Rev Growth

NVAX-25.1%

VERA698.6%

Gross Margin (TTM)

NVAX79.2%

VERA0.0%

Operating Margin (TTM)

NVAX0.0%

VERA0.0%

EBITDA Margin (TTM)

NVAX-24.0%

VERA0.0%

Net Margin (TTM)

NVAX-59.9%

VERA0.0%

FCF Margin (TTM)

NVAX-10.4%

VERAN/A

Net Income (TTM)

NVAX$-248M

VERA$-402M

FCF (TTM)

NVAX$-43M

VERA$-339M

EPS (TTM)

NVAX-$1.51

VERA-$5.59

ROE (TTM)

NVAX283.1%

VERA-8413.0%

ROA (TTM)

NVAX-2275.0%

VERA-6679.0%

ROIC (TTM)

NVAX40.0%

VERA-7272.0%

Cash

NVAX$191M

VERA$49M

Debt

NVAX$297M

VERA$75M

Net Cash/Debt

NVAX$-106M

VERA$-26M

Current Ratio (TTM)

NVAX2.33x

VERA10.92x

Quick Ratio (TTM)

NVAX2.23x

VERA10.50x

Debt/Equity (TTM)

NVAX6.07x

VERA0.18x

Debt/Assets (TTM)

NVAX0.0%

VERA0.0%

Interest Coverage (TTM)

NVAXN/A

VERAN/A

Net Debt/EBITDA (TTM)

NVAX0.00x

VERA0.00x

Beta

NVAX2.81

VERA1.13

52W Performance

NVAX43.3%

VERA-2.0%

YTD Performance

NVAX78.8%

VERA-38.5%

% from 52W High

NVAX-4.7%

VERA-46.7%

% from 52W Low

NVAX105.6%

VERA29.6%

Asset Turnover (TTM)

NVAX0.38x

VERA0.00x

FCF Yield (TTM)

NVAX-2.0%

VERA-15.8%

Earnings Yield (TTM)

NVAX-11.8%

VERA-18.7%

Dividend Yield (TTM)

NVAXN/A

VERAN/A

Rule of 40

NVAX-72.0

VERA0.0

EV/GP/RG

NVAXN/A

VERAN/A

Ticker research

View NVAX research View VERA research

Metric	NVAX Novavax Inc	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.10B	$2.14B
Enterprise Value	$2.20B	$2.17B
Price	$12.75	$29.88
P/E Ratio	N/A	N/A
P/S Ratio	5.07x	0.00x
EV/Sales	5.32x	0.00x
EV/EBITDA	4.05x	0.00x
P/B Ratio	45.86x	5.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-51.40x	-6.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	10.28x	19.87x
Revenue & Growth
Revenue (TTM)	$414M	$0
Revenue Growth (YoY)	-61.6%	N/A
Forward Rev Growth	-25.1%	698.6%
Profitability
Gross Margin (TTM)	79.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-24.0%	0.0%
Net Margin (TTM)	-59.9%	0.0%
FCF Margin (TTM)	-10.4%	N/A
Net Income (TTM)	$-248M	$-402M
FCF (TTM)	$-43M	$-339M
EPS (TTM)	-$1.51	-$5.59
ROE (TTM)	283.1%	-8413.0%
ROA (TTM)	-2275.0%	-6679.0%
ROIC (TTM)	40.0%	-7272.0%
Financial Health
Cash	$191M	$49M
Debt	$297M	$75M
Net Cash/Debt	$-106M	$-26M
Current Ratio (TTM)	2.33x	10.92x
Quick Ratio (TTM)	2.23x	10.50x
Debt/Equity (TTM)	6.07x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.81	1.13
52W Performance	43.3%	-2.0%
YTD Performance	78.8%	-38.5%
% from 52W High	-4.7%	-46.7%
% from 52W Low	105.6%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.00x
FCF Yield (TTM)	-2.0%	-15.8%
Earnings Yield (TTM)	-11.8%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-72.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NVAX research	View VERA research

Valuation

P/S Ratio

VERA

0.00x

NVAX

5.07x

EV/FCF

NVAX

-51.40x

VERA

-6.40x

Growth & revenue

Revenue Growth TTM

NVAX

-61.6%

Forward Revenue Growth

VERA

698.6%

NVAX

-25.1%

Profitability & performance

Gross Margin

NVAX

79.2%

VERA

0.0%

ROE

NVAX

283.1%

VERA

-8413.0%

FCF Yield %

NVAX

-2.0%

VERA

-15.8%

52-Week Performance

NVAX

43.3%

VERA

-2.0%

Detailed metrics comparison

NVAX

Novavax Inc

VERA

Vera Therapeutics, Inc

Market Cap

NVAX$2.10B

VERA$2.14B

Enterprise Value

NVAX$2.20B

VERA$2.17B

Price

NVAX$12.75

VERA$29.88

P/E Ratio

NVAXN/A

VERAN/A

P/S Ratio

NVAX5.07x

VERA0.00x

EV/Sales

NVAX5.32x

VERA0.00x

EV/EBITDA

NVAX4.05x

VERA0.00x

P/B Ratio

NVAX45.86x

VERA5.38x

P/FCF Ratio

NVAXN/A

VERAN/A

EV/FCF

NVAX-51.40x

VERA-6.40x

PEG Ratio

NVAXN/A

VERAN/A

Forward P/E (NTM)

NVAXN/A

VERAN/A

Forward P/S (NTM)

NVAX10.28x

VERA19.87x

Revenue (TTM)

NVAX$414M

VERA$0

Revenue Growth (YoY)

NVAX-61.6%

VERAN/A

Forward Rev Growth

NVAX-25.1%

VERA698.6%

Gross Margin (TTM)

NVAX79.2%

VERA0.0%

Operating Margin (TTM)

NVAX0.0%

VERA0.0%

EBITDA Margin (TTM)

NVAX-24.0%

VERA0.0%

Net Margin (TTM)

NVAX-59.9%

VERA0.0%

FCF Margin (TTM)

NVAX-10.4%

VERAN/A

Net Income (TTM)

NVAX$-248M

VERA$-402M

FCF (TTM)

NVAX$-43M

VERA$-339M

EPS (TTM)

NVAX-$1.51

VERA-$5.59

ROE (TTM)

NVAX283.1%

VERA-8413.0%

ROA (TTM)

NVAX-2275.0%

VERA-6679.0%

ROIC (TTM)

NVAX40.0%

VERA-7272.0%

Cash

NVAX$191M

VERA$49M

Debt

NVAX$297M

VERA$75M

Net Cash/Debt

NVAX$-106M

VERA$-26M

Current Ratio (TTM)

NVAX2.33x

VERA10.92x

Quick Ratio (TTM)

NVAX2.23x

VERA10.50x

Debt/Equity (TTM)

NVAX6.07x

VERA0.18x

Debt/Assets (TTM)

NVAX0.0%

VERA0.0%

Interest Coverage (TTM)

NVAXN/A

VERAN/A

Net Debt/EBITDA (TTM)

NVAX0.00x

VERA0.00x

Beta

NVAX2.81

VERA1.13

52W Performance

NVAX43.3%

VERA-2.0%

YTD Performance

NVAX78.8%

VERA-38.5%

% from 52W High

NVAX-4.7%

VERA-46.7%

% from 52W Low

NVAX105.6%

VERA29.6%

Asset Turnover (TTM)

NVAX0.38x

VERA0.00x

FCF Yield (TTM)

NVAX-2.0%

VERA-15.8%

Earnings Yield (TTM)

NVAX-11.8%

VERA-18.7%

Dividend Yield (TTM)

NVAXN/A

VERAN/A

Rule of 40

NVAX-72.0

VERA0.0

EV/GP/RG

NVAXN/A

VERAN/A

Ticker research

View NVAX research View VERA research

Metric	NVAX Novavax Inc	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.10B	$2.14B
Enterprise Value	$2.20B	$2.17B
Price	$12.75	$29.88
P/E Ratio	N/A	N/A
P/S Ratio	5.07x	0.00x
EV/Sales	5.32x	0.00x
EV/EBITDA	4.05x	0.00x
P/B Ratio	45.86x	5.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-51.40x	-6.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	10.28x	19.87x
Revenue & Growth
Revenue (TTM)	$414M	$0
Revenue Growth (YoY)	-61.6%	N/A
Forward Rev Growth	-25.1%	698.6%
Profitability
Gross Margin (TTM)	79.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-24.0%	0.0%
Net Margin (TTM)	-59.9%	0.0%
FCF Margin (TTM)	-10.4%	N/A
Net Income (TTM)	$-248M	$-402M
FCF (TTM)	$-43M	$-339M
EPS (TTM)	-$1.51	-$5.59
ROE (TTM)	283.1%	-8413.0%
ROA (TTM)	-2275.0%	-6679.0%
ROIC (TTM)	40.0%	-7272.0%
Financial Health
Cash	$191M	$49M
Debt	$297M	$75M
Net Cash/Debt	$-106M	$-26M
Current Ratio (TTM)	2.33x	10.92x
Quick Ratio (TTM)	2.23x	10.50x
Debt/Equity (TTM)	6.07x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.81	1.13
52W Performance	43.3%	-2.0%
YTD Performance	78.8%	-38.5%
% from 52W High	-4.7%	-46.7%
% from 52W Low	105.6%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.00x
FCF Yield (TTM)	-2.0%	-15.8%
Earnings Yield (TTM)	-11.8%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-72.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NVAX research	View VERA research